THURSDAY, February 8, 2024
03:00 p.m. – 06:00 p.m. Symposium Registration (Talbot Registration Desk)
FRIDAY, February 9, 2024
07:00 a.m. – 08:00 a.m. Registration, Breakfast and Exhibits
08:00 a.m. – 08:15 a.m. Welcoming Remarks and Introduction of Keynote Speaker Shahla Masood, MD
Keynote Lecture
08:15 a.m. – 09:00 a.m. Oncologic Anthropology: Correlation between African Ancestry and High-risk/Triple Negative Breast Cancer Lisa Newman, MD
Session I: Ductal Carcinoma in Situ
09:00 a.m. – 09:30 a.m. Changing the Term of Low-Grade Ductal Carcinoma in Situ to Ductal Neoplasia: A Pathologist’s Perspective Shahla Masood, MD
09:30 a.m. – 10:00 a.m. Should We Rename Ductal Carcinoma in Situ? A Surgeon’s Perspective Alastair M. Thompson, MD
10:00 a.m. – 10:30 a.m. BREAK AND EXHIBITS
10:30 a.m. – 11:00 a.m. Do We Still Need Radiation Therapy for Ductal Carcinoma in Situ? Julia R. White, MD
11:00 a.m. – 11:30 a.m. Optimizing Detection of Ductal Carcinoma in Situ Susan Weinstein, MD
11:30 a.m. – 12:00 p.m. Panel Discussion – Shahla Masood, MD; Lisa Newman, MD; Alastair M. Thompson, MD; Julia R. White, MD and Susan Weinstein, MD
12:00 p.m. – 01:00 p.m. LUNCH AND EXHIBITS
Session II: Breast Cancer Diagnosis
01:00 p.m. – 01:30 p.m. Breast Cancer Screening: Comparing Mammography, Ultrasound, MRI Susan Weinstein, MD
01:30 p.m. – 02:00 p.m. Contrast Enhanced Mammography, the Rising Phoenix Maxine S. Jochelson, MD
02:00 p.m. – 02:30 p.m. Use of Preoperative MRI in Newly Diagnosed Breast Cancer Patients Lisa Newman, MD
02:30 p.m. – 03:00 p.m. BREAK AND EXHIBITS
03:00 p.m. – 03:30 p.m. Why and When Should We Use PET/CT in Women with Breast Cancer Maxine S. Jochelson, MD
03:30 p.m. – 04:00 p.m. “High Risk” Breast Lesions on Core Biopsy: When to Excise? Thomas J. Lawton, MD
04:00 p.m. – 04:30 p.m. Panel Discussion – Maxine S. Jochelson, MD; Thomas J. Lawton, MD; Lisa Newman, MD; and Susan Weinstein, MD
SATURDAY, February 10, 2024
07:00 a.m. – 08:00 a.m. Registration, Breakfast and Exhibits
Session III: Breast Cancer Therapy
08:00 a.m. – 08:30 a.m. Management of High-Risk Cancer Patients Terry P. Mamounas, MD
08:30 a.m. – 09:00 a.m. Current Status of Nipple Sparing Mastectomy Armando E. Giuliano, MD
09:00 a.m. – 09:30 a.m. Latest Options for Immediate Post-Mastectomy Breast Reconstruction Hani Sbitany, MD
09:30 a.m. – 10:00 a.m. BREAK AND EXHIBITS
10:00 a.m. – 10:30 a.m. Axillary Staging after Neoadjuvant Chemotherapy Armando E Giuliano, MD
10:30 a.m. – 11:00 a.m. Is Omission of Surgery After Neoadjuvant Chemotherapy Ready for Prime Time? Alastair M. Thompson, MD
11:00 a.m. – 11:30 a.m. Surgical Techniques to Reduce Morbidity from Axillary Surgery Hani Sbitany, MD
11:30 a.m. – 12:00 p.m. Panel Discussion – Armando E. Giuliano, MD; Terry P. Mamounas, MD; Hani Sbitany, MD; and Alastair M. Thompson, MD
12:00 p.m. – 01:00 p.m. LUNCH AND EXHIBITS
Session IV: Breast Cancer Therapy
01:00 p.m. – 01:30 p.m. Advances in Breast Reconstruction: Sensation and Lymphatic Preservation Dung Nguyen, MD
01:30 p.m. – 02:00 p.m. Advances in Cancer Therapy Tailoring Radiation Therapy with Genomic Profiling Julia R. White, MD
02:00 p.m. – 02:30 p.m. Duration of Endocrine Therapy: How to Select Appropriate Candidates Terry P. Mamounas, MD
02:30 p.m. – 03:00 p.m. Novel Antibody Drug Conjugate Strategies Heather McArthur, MD
03:00 p.m. – 03:30 p.m. BREAK AND EXHIBITS
03:30 p.m. – 04:00 p.m. Regional Nodal Irradiation in Breast Cancer: When to Give and its Spectrum of Benefit Eric Brooks, MD
04:00 p.m. – 04:30 p.m. Updates in Immune Therapy for Breast Cancer Heather McArthur, MD
04:30 p.m. – 05:00 p.m. Panel Discussion – Eric Brooks, MD; Terry P. Mamounas, MD; Heather McArthur, MD; Dung Nguyen, MD; and Julia R. White, MD
SUNDAY, February 11, 2024
07:00 a.m. – 08:00 a.m. Registration and Breakfast
Session V: Contemporary Issues in Breast Cancer
08:00 a.m. – 08:30 a.m. Insights on Breast Cancer Molecular Subtypes Thomas J. Lawton, MD
08:30 a.m. – 09:00 a.m. Breast Tumor Conference Lisa Spiguel, MD
09:00 a.m. – 9:30 a.m. Fertility Presentation for Cancer Survivors Heather Macdonald, MD
9:30 a.m. – 10:00 a.m. Oligometastatic Breast Cancer and When to Offer Local Consolidative Therapy Eric Brooks, MD
10:00 a.m. – 1030 a.m. Menopause Management in Breast Cancer Survivors Heather Macdonald, MD
10:30 a.m. – 11:00 a.m. How to Identify Genetically Mutated Breast Cancer Shahla Masood, MD
11:00 a.m. – 11:30 a.m. Panel Discussion – Eric Brooks, MD; Thomas J. Lawton MD; Heather Macdonald, MD; Shahla Masood, MD; and Lisa Spiguel, MD
11:30 a.m. – 12:00 p.m. Closing Remarks Shahla Masood, MD